Physician profile
David P Patterson
NPI 1265697932
$9,726.10
in general payments reported to CMS, 2019-2025
13 companies · $1,806 in 2025
The $1,806 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $479 · 2021: $2,295 · 2022: $2,052 · 2023: $2,412 · 2024: $682 · 2025: $1,806.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,884 · Food and Beverage: $2,016.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,883.89 |
| Food and Beverage | $2,016.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $3,800.66 | 2019-2025 | |
| Arthrex, INC. | $1,748.08 | 2021-2023 | |
| Zimmer Biomet Holdings, INC. | $1,568.45 | 2025 | Oxford |
| Medacta USA, INC. | $1,045.05 | 2023-2024 | Amistem, Primary Shoulder |
| Stryker Corporation | $558.07 | 2021-2025 | Inspace, Iconix, Blueprint Patient Specific Instrumentation |
| Linvatec Corporation | $362.24 | 2019 | |
| Miach Orthopaedics, INC. | $247.18 | 2023 | |
| Smith+Nephew, INC. | $147.84 | 2021 | |
| Paragon 28, INC. | $147.79 | 2023 | Apex 3d |
| Catalyst Orthoscience | $48.90 | 2025 | |
| Vericel Corporation | $20.71 | 2021 | |
| Novartis Pharmaceuticals Corporation | $17.21 | 2019 | |
| Bioventus LLC | $13.92 | 2023 | L300 Go System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Patterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.